- Home
- AAPG vs ACLX Comparison
AAPG vs ACLX Comparison
Compare AAPG & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AAPG
- ACLX
- Stock Information
- Founded
- AAPG 2009
- ACLX 2015
- Country
- AAPG China
- ACLX United States
- Employees
- AAPG N/A
- ACLX N/A
- Industry
- AAPG Biotechnology: Pharmaceutical Preparations
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- AAPG Health Care
- ACLX Health Care
- Exchange
- AAPG Nasdaq
- ACLX Nasdaq
- Market Cap
- AAPG 3.6B
- ACLX 4.4B
- IPO Year
- AAPG 2025
- ACLX 2022
- Fundamental
- Price
- AAPG $33.87
- ACLX $90.01
- Analyst Decision
- AAPG Strong Buy
- ACLX Strong Buy
- Analyst Count
- AAPG 3
- ACLX 8
- Target Price
- AAPG $49.00
- ACLX $115.50
- AVG Volume (30 Days)
- AAPG 8.1K
- ACLX 427.8K
- Earning Date
- AAPG 11-19-2025
- ACLX 11-05-2025
- Dividend Yield
- AAPG N/A
- ACLX N/A
- EPS Growth
- AAPG N/A
- ACLX N/A
- EPS
- AAPG N/A
- ACLX N/A
- Revenue
- AAPG $54,524,554.00
- ACLX $35,898,000.00
- Revenue This Year
- AAPG N/A
- ACLX N/A
- Revenue Next Year
- AAPG $368.64
- ACLX $220.95
- P/E Ratio
- AAPG N/A
- ACLX N/A
- Revenue Growth
- AAPG N/A
- ACLX N/A
- 52 Week Low
- AAPG $16.50
- ACLX $47.86
- 52 Week High
- AAPG $48.45
- ACLX $100.34
- Technical
- Relative Strength Index (RSI)
- AAPG 47.99
- ACLX 57.21
- Support Level
- AAPG $30.93
- ACLX $85.00
- Resistance Level
- AAPG $34.31
- ACLX $91.68
- Average True Range (ATR)
- AAPG 0.81
- ACLX 4.14
- MACD
- AAPG 0.26
- ACLX -0.08
- Stochastic Oscillator
- AAPG 85.99
- ACLX 71.76
About AAPG Ascentage Pharma Group International American Depository Shares
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.